Observational Safety Study of Etanercept (Enbrel) for Treatment of Psoriasis

Study of Etanercept in the Treatment of Psoriasis in Adult Subjects

NCT00121615 ·Status: COMPLETED ·Phase: PHASE3

Safety and Efficacy of Etanercept in Patients With Psoriasis Who Failed to Respond to Other Biologic Treatments

NCT00967538 ·Status: COMPLETED ·Phase: PHASE4

Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

NCT01313221 ·Status: COMPLETED ·Phase: PHASE3

Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis

NCT00663052 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Etanercept in Patients With Psoriasis

NCT02258282 ·Status: UNKNOWN ·Phase: NA

Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients

NCT04398732 ·Status: COMPLETED

The Immunological Basis for Treatment Resistance to Anti-TNF Treatments

NCT01971346 ·Status: COMPLETED ·Phase: PHASE4

Evaluation of Add on Enstilar in Patients Using Otezla for Psoriasis

NCT03587194 ·Status: COMPLETED ·Phase: PHASE4

Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging

NCT05135312 ·Status: UNKNOWN ·Phase: PHASE4

Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

NCT00585650 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

The Safety & Efficacy of Etanercept in Psoriasis Patients Who Have Not Responded to Adalimumab

NCT00833729 ·Status: COMPLETED ·Phase: PHASE4

Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis

NCT00110981 ·Status: COMPLETED ·Phase: PHASE4

An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque Psoriasis

NCT00454584 ·Status: COMPLETED ·Phase: PHASE3

Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study

NCT01522742 ·Status: TERMINATED

Observational Study Evaluating Etanercept (Enbrel®) In Subjects With Plaque-Type Psoriasis In Usual Care Settings

NCT00708708 ·Status: COMPLETED

Study Evaluating Safety of Etanercept in Treatment of Patients With Moderate to Severe Psoriasiswith Etanercept

NCT00581165 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy of Combining nbUVB to Etanercept in Patients

NCT00640393 ·Status: COMPLETED ·Phase: PHASE4

PSUNRISE - Prospective Study Using Remicade in Psoriasis Patients With an Inadequate Response to Etanercept

NCT00527072 ·Status: COMPLETED ·Phase: PHASE3

Etanercept Plus UVB-311nm Phototherapy in Psoriasis

NCT00550030 ·Status: COMPLETED ·Phase: NA

Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

NCT01543204 ·Status: TERMINATED ·Phase: PHASE4

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

NCT03358290 ·Status: TERMINATED ·Phase: PHASE2

An Open-label Study to Evaluate the Efficacy of Re-treatment for Patients With a History of Etanercept Use

NCT01132235 ·Status: UNKNOWN ·Phase: PHASE4

Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

NCT01690299 ·Status: COMPLETED ·Phase: PHASE3

Optimizing Psoriasis Treatment of Etanercept Combined Methotrexate

NCT02313922 ·Status: COMPLETED ·Phase: PHASE4

Open Label Study Etanercept's Maintenance Dose in Obese Patients With Moderate to Severe Plaque Type Psoriasis

NCT00800982 ·Status: COMPLETED ·Phase: NA